 |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| Table 2. HIV-infected patients ever prescribed antiretroviral therapy by data source and race/ethnicity
|
|
|
|
|
View PDF
|
|
Data in Tables 1-2 are based on the following analyses:
- In ASD, among patients eligible for antiretroviral therapy (ART)
according to guidelines in place in 1999 (1), what is the proportion of
patients ever prescribed ART?
- In SHAS, among patients interviewed in 1999 with CD4 <500 cells/µL,
what is the proportion of patients who reported ever receiving ART to
treat HIV?
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Data Source |
Total |
|
White |
|
Black |
|
Hispanic |
|
Asian/Pacific
Islander |
|
American Indian/
Alaska Native |
| % |
Treated/
Eligible |
% |
Treated/
Eligible |
% |
Treated/
Eligible |
% |
Treated/
Eligible |
% |
Treated/
Eligible |
% |
Treated/
Eligible |
| ASD* |
95 |
8,483/8,923 |
|
95 |
2,672/2,809 |
|
95 |
3,878/4,084 |
|
95 |
1,778/1,866 |
|
96 |
90/94 |
|
91 |
43/47 |
| SHAS* |
91 |
1,230/1,357 |
92 |
376/408 |
88 |
555/630 |
94 |
251/268 |
100 |
6/6 |
90 |
18/20 |
|
|
|
|
*The ASD total contains 23 patients with unknown race/ethnicity. The SHAS total contains 25 patients with unknown race/ethnicity |
- Overall, the proportion of patients ever prescribed antiretroviral therapy was high: 91–95%.
- Overall, the proportion of persons ever prescribed antiretroviral therapy is probably higher in ASD because only patients eligible for antiretroviral therapy were included in the analysis. In addition, many of these patients have been observed since 1990, and have had greater opportunity to be prescribed antiretroviral therapy.
- Among those eligible, similar proportions of males and females were ever prescribed antiretroviral therapy in both the ASD and SHAS projects.
- Data from the SHDC and MOPTB studies were not available for this question.
|
|
|
|
|
|
|
|
|
|
